Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 966,005 |
|
|||||
| News | - | ||||||
| Day High | 26.55 | Low High |
|||||
| Day Low | 25.61 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Immunovant Inc | IMVT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.60 | -2.26% | 26.00 | 00:00:11 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 26.35 | 25.61 | 26.55 | 26.00 | 26.60 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 15,259 | 966,005 | $ 25.95 | $ 25,065,322 | - | 18.1615 - 45.58 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:56 | 25 | $ 25.13 | USD |
Immunovant Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.78B | 145.29M | - | 0 | -259.34M | -1.78 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Immunovant News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMVT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 25.28 | 26.67 | 24.67 | 25.57 | 999,901 | 0.72 | 2.85% |
| 1 Month | 31.47 | 31.81 | 24.67 | 26.86 | 1,347,590 | -5.47 | -17.38% |
| 3 Months | 32.95 | 33.13 | 24.67 | 28.62 | 1,113,626 | -6.95 | -21.09% |
| 6 Months | 44.42 | 45.58 | 24.67 | 34.17 | 1,283,892 | -18.42 | -41.47% |
| 1 Year | 21.83 | 45.58 | 18.1615 | 32.72 | 1,501,299 | 4.17 | 19.10% |
| 3 Years | 10.81 | 45.58 | 3.145 | 21.46 | 1,044,965 | 15.19 | 140.52% |
| 5 Years | 15.88 | 53.75 | 3.145 | 21.85 | 918,436 | 10.12 | 63.73% |
Immunovant Description
| Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn). |
